FIELD: medicine.
SUBSTANCE: present invention relates to medicine, specifically to immunology, and relates to increasing the effectiveness and / or safety of an allergen-specific immunotherapy (SIT) regimen. Method comprises administering a pharmaceutical composition comprising an interleukin-4 (IL-4) receptor antagonist immediately before or during SIT.
EFFECT: this provides effective immunotherapy at lower doses and frequency of allergen administration.
16 cl, 2 ex, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR THE TREATMENT OF ALLERGY AND INCREASING THE EFFICIENCY OF ALLERGEN-SPECIFIC IMMUNOTHERAPY BY INTRODUCING IL-4R INHIBITOR | 2014 |
|
RU2789047C2 |
| METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2014 |
|
RU2679141C2 |
| METHODS FOR INCREASING VACCINE EFFICIENCY BY INJECTING IL-4R ANTAGONIST | 2017 |
|
RU2753869C2 |
| METHODS FOR PREVENTING OR TREATING ALLERGIES BY INTRODUCING AN IL-4R ANTAGONIST | 2017 |
|
RU2777328C2 |
| METHODS FOR TREATMENT OR PREVENTION OF ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2690675C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2713406C2 |
| METHOD OF OBTAINING ALLERGEN EXTRACT | 2011 |
|
RU2572230C2 |
| METHOD OF TREATING SKIN INFECTION BY ADMINISTERING ANTAGONIST IL-4R | 2015 |
|
RU2704999C2 |
| METHOD OF PRODUCING ALLERGEN EXTRACT | 2011 |
|
RU2706685C2 |
| HUMAN ANTIBODIES TO Fel d1 AND METHODS OF USE THEREOF | 2013 |
|
RU2658491C2 |
